• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品中的杂质V:甲丙氨酯。

Impurities in drugs V: Meprobamate.

作者信息

Lawrence R C, Lovering E G, Poirier M A, Watson J R

出版信息

J Pharm Sci. 1980 Dec;69(12):1444-5. doi: 10.1002/jps.2600691227.

DOI:10.1002/jps.2600691227
PMID:7463335
Abstract

One lot of meprobamate raw material and 28 lots of tablets were examined for impurities by TLC. All lots contained di-(2-methyl-2-propyl-3-carbamoyloxypropyl) carbonate (V) at levels that ranged between 0.1 and 1.0% of the total drug content. Nine lots also contained low levels of a second impurity (approximately 0.1%), and one of these lots contained a third impurity (approximately 0.1%), neither of which was identified. Estimates of the unidentified impurities were based on the assumption of a TLC response with furfural-hydrochloric acid spray equivalent to that of meprobamate. Compound V was identified by mass spectrometry and PMR and IR spectroscopy and by comparison of the TLC Rf value to that of a synthesized sample of V.

摘要

采用薄层色谱法对一批甲丙氨酯原料药和28批片剂进行杂质检查。所有批次中均含有二-(2-甲基-2-丙基-3-氨甲酰氧基丙基)碳酸酯(V),其含量占药物总含量的0.1%至1.0%。9个批次还含有低水平的第二种杂质(约0.1%),其中一个批次含有第三种杂质(约0.1%),均未鉴定出具体成分。未鉴定杂质的含量估计是基于糠醛-盐酸喷雾薄层色谱响应与甲丙氨酯相当的假设。化合物V通过质谱、核磁共振氢谱和红外光谱以及将薄层色谱比移值与V的合成样品进行比较来鉴定。

相似文献

1
Impurities in drugs V: Meprobamate.药品中的杂质V:甲丙氨酯。
J Pharm Sci. 1980 Dec;69(12):1444-5. doi: 10.1002/jps.2600691227.
2
Impurities in drugs III: Trihexyphenidyl.药物中的杂质III:苯海索。
J Pharm Sci. 1979 Sep;68(9):1124-7. doi: 10.1002/jps.2600680917.
3
Impurities in drugs IV: Indomethacin.药物中的杂质IV:吲哚美辛。
J Pharm Sci. 1980 Feb;69(2):187-9. doi: 10.1002/jps.2600690218.
4
Impurities in drugs I: Imipramine, desipramine, and their formulations.药品中的杂质I:丙咪嗪、地昔帕明及其制剂
J Pharm Sci. 1977 Jul;66(7):1015-8. doi: 10.1002/jps.2600660730.
5
Impurities in drugs II: meperidine and its formulations.药品中的杂质II:哌替啶及其制剂
J Pharm Sci. 1978 Jul;67(7):958-61. doi: 10.1002/jps.2600670723.
6
Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.美普他酚药物中有关物质的工艺杂质的识别、分离、特性鉴定及反应因子测定。
J Pharm Biomed Anal. 2011 Jan 5;54(1):208-12. doi: 10.1016/j.jpba.2010.07.018. Epub 2010 Jul 29.
7
[Studies on psychotropic drugs. Determination of meprobamate by means of TLC-FID analyser (author's transl)].
Eisei Shikenjo Hokoku. 1978(96):67-70.
8
Quantitative determination of carisoprodol, phenacetin, and caffeine in tablets by near-IR spectrometry and their identification by TLC.采用近红外光谱法对片剂中卡立普多、非那西丁和咖啡因进行定量测定,并通过薄层色谱法对其进行鉴别。
J Pharm Sci. 1974 Jun;63(6):912-6. doi: 10.1002/jps.2600630621.
9
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
10
Stability-indicating HPLC method for the determination of impurities in meprobamate with refractive index detection.
J Chromatogr Sci. 2010 Mar;48(3):212-8. doi: 10.1093/chromsci/48.3.212.

引用本文的文献

1
Hydrolysis and determination of meprobamate.
Pharm Weekbl Sci. 1983 Aug 26;5(4):186-8. doi: 10.1007/BF01961480.